Cite
Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis
MLA
Shaun Flynn, et al. “Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis.” Journal of Medicinal Chemistry, vol. 51, Feb. 2008, pp. 1695–705. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....64dafc54f7435bfc86e716abcc843b0d&authtype=sso&custid=ns315887.
APA
Shaun Flynn, James Bready, Shawn Harriman, Vinod F. Patel, Zhiyang Zhao, Alexander M. Long, Anthony Polverino, Jean-Christophe Harmange, Michael Morrison, Jay Larrow, Nicholas Doerr, Daniel S. La, Juan Estrada, Thomas DeMelfi, Julie Belzile, Matthew Weiss, Julie Flynn, Yohannes Teffera, Douglas A. Whittington, … Ling Wang. (2008). Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis. Journal of Medicinal Chemistry, 51, 1695–1705.
Chicago
Shaun Flynn, James Bready, Shawn Harriman, Vinod F. Patel, Zhiyang Zhao, Alexander M. Long, Anthony Polverino, et al. 2008. “Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis.” Journal of Medicinal Chemistry 51 (February): 1695–1705. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....64dafc54f7435bfc86e716abcc843b0d&authtype=sso&custid=ns315887.